Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.02B | $-47.10M | $-0.66 |
| 2024 | $948.87M | $-94.10M | $-1.00 |
| 2023 | $935.92M | $-122.23M | $-1.29 |
Social Signal Score
Earnings
Thu, Nov 12(in 3 months)
Consensus estimate $0.19 per share
Typical surprise -71.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 12$0.20 vs $0.15beat
- Tue, May 12$0.18 vs $0.12beat
- Thu, Mar 26$-0.38 vs $0.05miss
- Wed, Dec 3$-0.03 vs $0.05miss
Estimates and results for LMRI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
LMRIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsseekingalpha.com·2d ago·Positive
Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·2d ago·Neutral
Lumexa Imaging Q2 Earnings Call Highlights Lumexa Imaging NASDAQ: LMRI reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance.
View source ↗
